These shifts carry a double sting. First, more people are becoming unwell, or are unable to work to their full capacity, at significant economic and personal cost. Second, the cost of treating many conditions has risen sharply, which is particularly confronting for those without insurance or access to robust public health systems. For life insurers and group schemes, that combination is already putting pressure on loss ratios and pricing, particularly in group risk and income protection portfolios.